Dispute panel wants more CorCap data

No changes foreseen in FDA's regulation of DES technology

Few surprises, little new FDA action seen for addressing DES

Cost containment a central issue in state health plans

Carotid stent seen as effective with inexperienced surgeons

Drum-beat of battle continues in effort to block imaging cuts

CorCap panel outcome hints at tightening of clinical trial rules

Too little data for RESUS III as consent trial seen as onerous

Hemopure advocates say lives saved, opponents focus on SAEs

Drum-beat of battle continues in effort to block imaging cuts